US · Basic Materials · Specialty Chemicals
EPS came in at 1.49 against a street estimate of 1.40 — a beat of 6.4%.
Analysts rate Balchem Corporation a buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $200.75.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.07% |
| Vanguard Portfolio Management, LLC | 6.83% |
| Vanguard Capital Management, LLC | 4.46% |
| State Street Corp | 3.86% |
| Conestoga Capital Advisors, LLC | 3.39% |
| Wasatch Advisors LP | 3.27% |
| Geode Capital Management, LLC | 3.26% |
| Morgan Stanley - Brokerage Accounts | 2.67% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-31 |
| Results announced · Q3 2026 | 2026-07-31 |
| Material agreement · Q3 2026 | 2026-07-27 |
| Shareholder vote results · Q2 2026 | 2026-06-22 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-27 |
| Annual report FY2025 | 2026-02-20 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Balchem Corporation — free to start.
Google PlayApp StoreData updated 2026-08-05.